{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:26:12Z","timestamp":1763447172867,"version":"3.45.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K16012"],"award-info":[{"award-number":["20K16012"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jphs.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:35:33Z","timestamp":1758152133000},"page":"268-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone deacetylase inhibitors suppress retinal angiogenesis by preventing endothelial cell proliferation and accelerating VEGF degradation"],"prefix":"10.1016","volume":"159","author":[{"given":"Akane","family":"Morita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-5870","authenticated-orcid":false,"given":"Tsutomu","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2025.09.005_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1091794","article-title":"The role of class IIa histone deacetylases in regulating endothelial function","volume":"14","author":"Shen","year":"2023","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.jphs.2025.09.005_bib2","article-title":"Histone deacetylases: regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis","volume":"11","author":"Yang","year":"2024","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.onc.1205108","article-title":"Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling","volume":"21","author":"Deroanne","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jphs.2025.09.005_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/mp800178b","article-title":"N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis","volume":"6","author":"Kim","year":"2009","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.jphs.2025.09.005_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/exd.13159","article-title":"Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism","volume":"26","author":"Hrgovic","year":"2017","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jphs.2018.10.004","article-title":"Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy","volume":"138","author":"Iizuka","year":"2018","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.jphs.2025.09.005_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/md19080471","article-title":"Largazole inhibits ocular angiogenesis by modulating the expression of VEGFR2 and p21","volume":"19","author":"Qiu","year":"2021","journal-title":"Mar Drugs"},{"issue":"2","key":"10.1016\/j.jphs.2025.09.005_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2008.11.012","article-title":"Targeting tumor angiogenesis with histone deacetylase inhibitors","volume":"280","author":"Ellis","year":"2009","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.jphs.2025.09.005_bib9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jphs.2025.09.005_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.yexcr.2005.10.030","article-title":"Angiogenesis in the mouse retina: a model system for experimental manipulation","volume":"312","author":"Uemura","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jphs.2025.09.005_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exer.2014.01.009","article-title":"Effects of pre- and post-natal treatment with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on retinal vascular development and patterning in mice","volume":"120","author":"Morita","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jphs.2025.09.005_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exer.2014.11.005","article-title":"Effects of mTOR inhibition on normal retinal vascular development in the mouse","volume":"129","author":"Yagasaki","year":"2014","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.jphs.2025.09.005_bib13","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1248\/bpb.b17-00475","article-title":"Mammalian target of rapamycin (mTOR) as a potential therapeutic target in pathological ocular angiogenesis","volume":"40","author":"Nakahara","year":"2017","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/dvdy.24484","article-title":"A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina","volume":"246","author":"Morita","year":"2017","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jphs.2025.09.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2023.104626","article-title":"Role of mammalian target of rapamycin in the formation and progression of retinopathy of prematurity-like vascular abnormalities in neonatal rats","volume":"152","author":"Nakano","year":"2024","journal-title":"Microvasc Res"},{"issue":"7 Pt 1","key":"10.1016\/j.jphs.2025.09.005_bib16","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.jphs.2025.09.005_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J Cell Biol"},{"issue":"9","key":"10.1016\/j.jphs.2025.09.005_bib18","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI126655","article-title":"Roles of HIFs and VEGF in angiogenesis in the retina and brain","volume":"129","author":"Rattner","year":"2019","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00441-020-03276-9","article-title":"The process of revascularization in the neonatal mouse retina following short-term blockade of vascular endothelial growth factor receptors","volume":"382","author":"Morita","year":"2020","journal-title":"Cell Tissue Res"},{"issue":"11","key":"10.1016\/j.jphs.2025.09.005_bib20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1248\/bpb.b14-00487","article-title":"Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy","volume":"37","author":"Yagasaki","year":"2014","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.jphs.2025.09.005_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","article-title":"Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes","volume":"7","author":"Kim","year":"2001","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jphs.2025.09.005_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol Med -Chir"},{"issue":"2","key":"10.1016\/j.jphs.2025.09.005_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3892\/mmr.2013.1834","article-title":"Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells","volume":"9","author":"Zhang","year":"2014","journal-title":"Mol Med Rep"},{"issue":"11","key":"10.1016\/j.jphs.2025.09.005_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s12094-016-1494-0","article-title":"Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1\u03b1\/VEGF signals","volume":"18","author":"Zhao","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jphs.2025.09.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108405","article-title":"Exposure to valproic acid (VPA) resulted in alterations in the expression of angiogenic genes (NRP-1, VEGFA, VEGFR-2 and sFlt1) and histological modifications in the placenta of mice (Mus musculus)","volume":"119","author":"Ruyani","year":"2023","journal-title":"Reprod Toxicol"},{"issue":"9","key":"10.1016\/j.jphs.2025.09.005_bib26","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059918","article-title":"TGF-beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis","volume":"8","author":"Geng","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.jphs.2025.09.005_bib28","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jphs.2025.09.005_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10928-013-9323-3","article-title":"Sex related differences on valproic acid pharmacokinetics after oral single dose","volume":"40","author":"Ibarra","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jphs.2025.09.005_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/biomedicines8020022","article-title":"Understanding failure and improving treatment using HDAC inhibitors for prostate cancer","volume":"8","author":"Rana","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.005_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.jphs.2025.09.005_bib33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jnr.23358","article-title":"Rapamycin prevents N-methyl-D-aspartate-induced retinal damage through an ERK-dependent mechanism in rats","volume":"92","author":"Ichikawa","year":"2014","journal-title":"J Neurosci Res"},{"issue":"10","key":"10.1016\/j.jphs.2025.09.005_bib34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm.1873","article-title":"The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis","volume":"14","author":"Sapieha","year":"2008","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jphs.2025.09.005_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.exer.2011.12.005","article-title":"The deletion of Math5 disrupts retinal blood vessel and glial development in mice","volume":"96","author":"Edwards","year":"2012","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.jphs.2025.09.005_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/dvdy.263","article-title":"Pharmacological depletion of retinal neurons prevents vertical angiogenic sprouting without affecting the superficial vascular plexus","volume":"250","author":"Morita","year":"2021","journal-title":"Dev Dyn"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132500091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132500091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:20:19Z","timestamp":1763446819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134786132500091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S134786132500091X"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.09.005","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitors suppress retinal angiogenesis by preventing endothelial cell proliferation and accelerating VEGF degradation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}